News
Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...
StockStory.org on MSN4h
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals StocksEarnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Johnson & Johnson (JNJ), Merck (MRK), and Pfizer (PFE), are under pressure on Wednesday after President Trump announced that ...
Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...
Investors are nervous. As of 9:55 a.m. ET Wednesday morning, shares of Roche Holding ( RHHBY -2.81%) are down 2.3%, Eli Lilly ( LLY -4.38%) stock is off 3.2%, and AstraZeneca ( AZN -4.87%) is doing ...
Global drugmakers' stocks dropped across the board after US President Donald Trump reiterated plans for a "major" tariff on ...
Explore more
Shares in many large drugmakers initially fell Wednesday on the president's threat, only to rebound later when he announced a ...
Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...
But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...
After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...
Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ...
23hon MSN
Eli Lilly is reaping the benefits from its innovation in diabetes and obesity management, with therapies like Mounjaro and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results